A.N. Naegeli
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Rheumatoid Arthritis Research and Therapies, Psoriasis: Treatment and Pathogenesis, Systemic Lupus Erythematosus Research, Dermatology and Skin Diseases, T-cell and B-cell Immunology
Most-Cited Works
- → Patient-reported fatigue and its impact on patients with systemic lupus erythematosus(2013)59 cited
- → PDB46 CONTRIBUTIONS OF AND RELATIONSHIP BETWEEN EXPECTATIONS ABOUT AND EXPERIENCES WITH INSULIN THERAPY TO TREATMENT SATISFACTION IN INSULIN-NAÏVE PATIENTS WITH TYPE-2 DIABETES(2009)1 cited
- → PMS58 Pilot Validation of the Brief Fatigue Inventory ‘Fatigue at its Worst’ Item in Patients with Rheumatoid Arthritis(2011)1 cited
- → PMS66 Conceptual Model of the Impact of Hip Fracture on Patients' Lives(2011)1 cited
- → Psychometric Evaluation of the Psoriasis Symptoms Scale in Patients with Moderate to Severe Plaque Psoriasis(2018)
- → Ixekizumab efficacy and safety in moderate-to-severe genital psoriasis(2018)
- → THU0422 Psychometric Properties of the Brief Fatigue Inventory-Short Form in Systemic Lupus Erythematosus(2014)
- → PMS60 Experiences of Patients with Rheumatoid Arthritis in the US and UK: A Cross-Cultural Comparison(2011)
- → PCN102 The Impact of Muscle Wasting or Weakness in Advanced Pancreatic Cancer Patients: Development of a Conceptual Model(2012)
- → PMS74 PILOT VALIDATION OF THE BRIEF PAIN INVENTORY ‘PAIN AT ITS WORST’ ITEM IN PATIENTS WITH RHEUMATOID ARTHRITIS(2011)